Consequences of nigrostriatal denervation on the gamma-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes - PubMed (original) (raw)
doi: 10.1212/wnl.46.3.802.
M T Herrero, R Levy, B Faucheux, M Ruberg, J Guillen, M R Luquin, J Guridi, F Javoy-Agid, Y Agid, J A Obeso, E C Hirsch
Affiliations
- PMID: 8618687
- DOI: 10.1212/wnl.46.3.802
Consequences of nigrostriatal denervation on the gamma-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes
M Vila et al. Neurology. 1996 Mar.
Abstract
To examine the effects of nigrostriatal denervation on the substantia nigra pars reticulata (SNpr), one of the main outputs of the basal ganglia, we used quantitative in situ hybridization to analyze the messenger RNA coding for Mr 67,000 glutamic acid decarboxylase (GAD67 mRNA) in the SNpr neurons from patients with Parkinson's disease (PD), monkeys rendered parkinsonian by 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine (MPTP), and their respective controls. In MPTP-intoxicated monkeys, the expression of GAD67 mRNA was increased in the SNpr neurons, and the increase was reversed by L-dopa treatment. There were no differences in the level of GAD67 mRNA between PD patients who had been treated with L-dopa and control subjects. Combined with the previously reported increased expression of GAD67 mRNA in the internal segment of the pallidum of MPTP-intoxicated monkeys, these data suggest that the gamma-aminobutyric acid (GABAergic) activity of the output system of the basal ganglia is globally increased by nigrostriatal denervation. We also analyzed the level of GAD67 mRNA expression in the superior colliculus, a structure that receives the inhibitory influence of the GABAergic neurons of the SNpr and that is involved in eye movement control. GAD67 mRNA expression was reduced in both MPTP-intoxicated monkeys, whether or not they received L-dopa therapy, and PD patients, compared to their respective controls. This decrease may result from the hyperactivity of the inhibitory nigrotectal pathway, but also from other influences since it was not corrected by L-dopa therapy. These changes may account for the slight ocular motor and visuospatial cognitive impairment occurring in PD, even after L-dopa therapy.
Similar articles
- Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA.
Vila M, Levy R, Herrero MT, Ruberg M, Faucheux B, Obeso JA, Agid Y, Hirsch EC. Vila M, et al. J Neurosci. 1997 Jan 15;17(2):765-73. doi: 10.1523/JNEUROSCI.17-02-00765.1997. J Neurosci. 1997. PMID: 8987798 Free PMC article. - Effects of nigrostriatal denervation and L-dopa therapy on the GABAergic neurons in the striatum in MPTP-treated monkeys and Parkinson's disease: an in situ hybridization study of GAD67 mRNA.
Levy R, Herrero MT, Ruberg M, Villares J, Faucheux B, Guridi J, Guillen J, Luquin MR, Javoy-Agid F, Obeso JA, et al. Levy R, et al. Eur J Neurosci. 1995 Jun 1;7(6):1199-209. doi: 10.1111/j.1460-9568.1995.tb01110.x. Eur J Neurosci. 1995. PMID: 7582093 - Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum.
Herrero MT, Levy R, Ruberg M, Luquin MR, Villares J, Guillen J, Faucheux B, Javoy-Agid F, Guridi J, Agid Y, Obeso JA, Hirsch EC. Herrero MT, et al. Neurology. 1996 Jul;47(1):219-24. doi: 10.1212/wnl.47.1.219. Neurology. 1996. PMID: 8710082 - A guide to neurotoxic animal models of Parkinson's disease.
Tieu K. Tieu K. Cold Spring Harb Perspect Med. 2011 Sep;1(1):a009316. doi: 10.1101/cshperspect.a009316. Cold Spring Harb Perspect Med. 2011. PMID: 22229125 Free PMC article. Review. - The neuropathology of GABA neurons in extrapyramidal disorders.
Lloyd KG. Lloyd KG. J Neural Transm Suppl. 1980;(16):217-27. doi: 10.1007/978-3-7091-8582-7_25. J Neural Transm Suppl. 1980. PMID: 6448916 Review.
Cited by
- Changes in the neuronal activity in the pedunculopontine nucleus in chronic MPTP-treated primates: an in situ hybridization study of cytochrome oxidase subunit I, choline acetyl transferase and substance P mRNA expression.
Gomez-Gallego M, Fernandez-Villalba E, Fernandez-Barreiro A, Herrero MT. Gomez-Gallego M, et al. J Neural Transm (Vienna). 2007 Mar;114(3):319-26. doi: 10.1007/s00702-006-0547-x. Epub 2006 Sep 21. J Neural Transm (Vienna). 2007. PMID: 16988796 - Surgery for Parkinson's disease.
Obeso JA, Guridi J, Obeso JA, DeLong M. Obeso JA, et al. J Neurol Neurosurg Psychiatry. 1997 Jan;62(1):2-8. doi: 10.1136/jnnp.62.1.2. J Neurol Neurosurg Psychiatry. 1997. PMID: 9010390 Free PMC article. No abstract available. - Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.
Duty S, Jenner P. Duty S, et al. Br J Pharmacol. 2011 Oct;164(4):1357-91. doi: 10.1111/j.1476-5381.2011.01426.x. Br J Pharmacol. 2011. PMID: 21486284 Free PMC article. Review. - Intrastriatal mesencephalic grafts affect neuronal activity in basal ganglia nuclei and their target structures in a rat model of Parkinson's disease.
Nakao N, Ogura M, Nakai K, Itakura T. Nakao N, et al. J Neurosci. 1998 Mar 1;18(5):1806-17. doi: 10.1523/JNEUROSCI.18-05-01806.1998. J Neurosci. 1998. PMID: 9465005 Free PMC article. - Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA.
Vila M, Levy R, Herrero MT, Ruberg M, Faucheux B, Obeso JA, Agid Y, Hirsch EC. Vila M, et al. J Neurosci. 1997 Jan 15;17(2):765-73. doi: 10.1523/JNEUROSCI.17-02-00765.1997. J Neurosci. 1997. PMID: 8987798 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous